INTRODUCTION
The contemporary globalization of healthcare has fundamentally altered the territorial foundations of medical regulation. Healthcare services, once governed almost exclusively within domestic legal systems, are increasingly consumed across national borders as patients seek affordable, timely, and specialized treatment abroad. This trans-nationalization of healthcare—commonly described as cross-border medical tourism—now constitutes a significant component of the global health economy and raises profound questions regarding regulatory authority, legal accountability, and patient protection.1
Cross-border medical tourism is particularly pronounced within regional groupings characterized by geographical proximity, shared historical linkages, and uneven healthcare capacity.2 South Asia exemplifies such a regional configuration. Large population bases, persistent disparities in health infrastructure, and asymmetrical distribution of specialized medical services have produced sustained patterns of outbound patient mobility from lower-capacity systems to more advanced healthcare markets.3 Within this regional landscape, Bangladesh has emerged as a major sending state, while India has developed into a primary destination for advanced diagnostics and tertiary care.4
The steady movement of Bangladeshi patients across borders reflects structural limitations within domestic healthcare delivery, including constrained specialist availability, limited high-end diagnostic capacity, and uneven quality assurance mechanisms.5 Yet cross-border patient mobility cannot be reduced to a purely economic transaction between consumer and provider. When medical care is accessed outside the patient’s home jurisdiction, foundational assumptions underlying domestic health regulation—such as licensing oversight, malpractice liability, consumer protection, and continuity of care—become unsettled.6 Patients may find themselves situated within fragmented legal environments in which responsibility is diffused across multiple jurisdictions and regulatory authorities.7
International law presently offers no comprehensive binding regime governing cross-border healthcare as a distinct regulatory field. Instead, normative guidance is dispersed across international human rights law, global health governance instruments, migration frameworks, and domestic regulatory regimes.8 The right to the highest attainable standard of physical and mental health, as articulated in international human rights instruments, imposes obligations on states to ensure availability, accessibility, acceptability, and quality of healthcare.9 However, the extent to which these obligations apply extraterritorially in the context of patient mobility remains legally contested.10 This normative indeterminacy is especially consequential in regional medical corridors where patient movement is routine but formal legal coordination is limited.
Ethical concerns further complicate the governance of cross-border medical tourism. Power asymmetries between patients and providers, linguistic and informational barriers, and commercial pressures may undermine informed consent and patient autonomy.11 Destination states must also confront distributive justice questions regarding the allocation of scarce healthcare resources between domestic populations and foreign patients.12 Sending states, for their part, face unresolved questions regarding their duty to regulate outbound medical travel and to protect citizens from foreseeable harm abroad.13
Despite the rapid expansion of cross-border medical tourism in South Asia, existing scholarship has largely concentrated on economic performance and public health outcomes, while providing comparatively limited attention to integrated legal and ethical governance.14 Few studies systematically examine how domestic health law, international human rights obligations, and regional cooperation mechanisms intersect to shape the legal position of Bangladeshi patients seeking treatment abroad.15 This conceptual gap constrains the development of coherent regulatory strategies capable of addressing patient vulnerability, accountability deficits, and structural inequities.
This article addresses that gap through a doctrinal and normative analysis of the legal, ethical, and policy dimensions of Bangladeshi patient mobility within South Asia. It advances the central argument that effective governance of cross-border healthcare requires a rights-based regulatory architecture supported by harmonized legal standards, bilateral cooperation, and institutional accountability. By situating Bangladesh–India medical travel within broader debates on international health law and patient protection, the study seeks to contribute to the construction of principled, context-sensitive regulatory models for the South Asian medical corridor.
Methodology
This study adopts a qualitative doctrinal research methodology, grounded in systematic legal analysis, interpretation, and synthesis of primary and secondary legal materials. The doctrinal approach is appropriate because the research primarily examines normative legal frameworks, regulatory gaps, and policy coherence governing medical tourism, cross-border healthcare access, and patient mobility affecting Bangladesh. Rather than generating new empirical data, the study focuses on critically evaluating existing legal texts, jurisprudence, and scholarly commentary to develop principled arguments and normative recommendations.
LITERATURE REVIEW
Scholarly engagement with cross-border healthcare and medical tourism has expanded considerably over the past two decades, producing a multidisciplinary body of work spanning public health, economics, ethics, and governance. However, within this growing literature, doctrinal legal analysis—particularly concerning the legal obligations of sending and receiving states toward cross-border patients—remains comparatively underdeveloped. This review critically synthesizes existing scholarship in four interconnected domains: (i) determinants of Bangladeshi patient mobility, (ii) regulatory and policy barriers, (iii) legal and institutional protection frameworks, and (iv) ethical and human rights–based governance. It demonstrates that while empirical and policy-oriented studies illuminate why patients travel, they do not adequately address how law should regulate such mobility or protect patient rights. This doctrinal gap directly informs the present study’s central objective: to evaluate the adequacy of Bangladesh’s legal framework governing cross-border healthcare and to identify normative pathways for reform.
A substantial body of literature establishes that economic considerations constitute a primary driver of Bangladeshi patient mobility to India. Zakaria et al. find that cost differentials for specialized treatments—particularly cardiology, oncology, and orthopedic care—create powerful incentives for cross-border travel.16 These findings situate patient mobility within broader structural deficiencies of Bangladesh’s domestic healthcare system, including shortages of specialized facilities and long waiting periods.17 Connell’s global analysis similarly concludes that price asymmetries between countries are among the most persistent determinants of international medical tourism flows.18
Beyond cost, quality perception emerges as an equally influential factor. Zakaria et al. report that Bangladeshi patients associate Indian hospitals with advanced diagnostic technologies, specialized physicians, and higher clinical success rates.19 Connell observes that destination choice in medical tourism is frequently driven by reputational hierarchies of healthcare systems rather than objective clinical comparisons alone.20 Cultural and linguistic proximity further enhances India’s attractiveness, as shared language, dietary practices, and religious customs reduce psychological and social barriers to care.21
While these studies convincingly explain why Bangladeshi patients seek treatment abroad, they largely frame mobility as a market-driven phenomenon. They seldom interrogate whether states possess legal obligations to mitigate the structural inequalities that compel patients to exit domestic systems. Consequently, the literature inadequately addresses whether outward medical travel reflects an exercise of patient autonomy or a manifestation of systemic failure engaging state responsibility. This conceptual gap necessitates a doctrinal inquiry grounded in constitutional law, health legislation, and international human rights norms.
Another strand of scholarship focuses on regulatory and administrative barriers affecting cross-border healthcare. Iftikhar et al. demonstrate that visa regimes, documentary requirements, and bureaucratic delays constitute significant impediments to timely medical travel in South Asia.22 Delayed visa approvals for specialized treatment frequently leads to postponed surgeries and worsened health outcomes.23 Bookman and Bookman similarly observe that fragmented regulatory environments create inefficiencies and unequal access within global medical tourism markets.24
These analyses, however, conceptualize barriers primarily as policy failures rather than legal deficiencies. Little attention is given to whether patients possess enforceable rights to expedited medical visas, transparent procedures, or administrative review. The absence of such doctrinal engagement obscures the potential role of administrative law principles—such as reasonableness, non-arbitrariness, and procedural fairness—in regulating cross-border healthcare governance. The present study responds by examining whether Bangladesh’s legal system recognizes positive obligations to facilitate access to essential medical travel.
Legal and institutional dimensions of cross-border healthcare receive comparatively limited treatment in South Asian scholarship. Ssengooba emphasizes that legal frameworks, including bilateral agreements, national health policies, and liability regimes, profoundly shape patient access in border regions.25 Yet Bangladesh and India lack comprehensive legal instruments specifically governing cross-border patient protection, malpractice liability, or continuity of care.26
Comparative literature from the European Union demonstrates the transformative potential of legal harmonization. Rechel et al. show that the EU Cross-Border Healthcare Directive establishes enforceable patient rights, reimbursement mechanisms, and standards of care applicable across Member States.27 This model illustrates how supranational legal architecture can convert patient mobility from a discretionary practice into a rights-based entitlement.
Despite the relevance of such comparative experiences, South Asian scholarship rarely explores how similar normative structures could be adapted within regional frameworks such as SAARC. The absence of doctrinal analysis concerning treaty-making competence, regional cooperation mechanisms, and domestic incorporation of international obligations constitutes a major lacuna. This study fills that gap by evaluating the feasibility of rights-oriented regional legal instruments for South Asia.
Ethical and human rights–based analyses constitute a fourth major strand. Andanda advances a rights-based framework arguing that cross-border healthcare must be governed by principles derived from the right to health, informed consent, and non-discrimination.28 Ethical vulnerability is heightened for patients from low- and middle-income countries, who may encounter language barriers, limited health literacy, and informational asymmetry.29
Xu et al., examining South Korea, caution that unregulated medical tourism can divert healthcare resources toward foreign patients, thereby disadvantaging domestic populations.30 Connell similarly warns that medical tourism may produce dual healthcare systems privileging affluent patients while marginalizing others.31 These findings highlight distributive justice concerns but stop short of articulating concrete legal duties owed by states to prevent such inequities.
Thus, while ethical scholarship articulates normative values, it rarely translates them into binding legal standards or enforcement mechanisms. The present research bridges this divide by situating ethical principles within constitutional, statutory, and international legal frameworks applicable to Bangladesh.
Collectively, existing literature provides strong empirical and normative foundations but lacks an integrated doctrinal analysis of cross-border healthcare governance from Bangladesh’s perspective. There is limited engagement with questions of state responsibility, enforceable patient rights, or legal accountability mechanisms. Moreover, comparative insights are seldom operationalized into context-sensitive reform proposals. This study addresses these deficiencies by conducting a qualitative doctrinal examination of domestic, regional, and international legal frameworks to assess whether Bangladesh’s existing legal order adequately protects cross-border patients and to propose normative pathways toward rights-based regulatory reform.
While the reviewed literature provides significant insights, there remains a gap in integrating patient experiences, legal protections, and ethical governance in the South Asian medical corridor. Most studies focus separately on patient motivations, policy barriers, or legal frameworks, but few analyze how these dimensions interact to affect Bangladeshi patient mobility. This study addresses that gap by synthesizing empirical data, legal analysis, and comparative policy review to propose actionable reforms.
FINDINGS AND DISCUSSION
This study finds that Bangladesh lacks a dedicated legal framework governing outbound medical travel, resulting in a normative vacuum for the protection of patients who seek healthcare abroad. Existing health statutes and professional regulatory regimes are territorially confined and do not contemplate state obligations toward citizens obtaining treatment outside national borders. Although the Constitution guarantees the right to life and personal liberty, judicial interpretation has largely confined this guarantee to domestic healthcare delivery, leaving its application to cross-border medical access underdeveloped.32
The analysis further demonstrates that responsibility for protecting cross-border patients is fragmented between sending and receiving states. International human rights law recognizes the right to the highest attainable standard of health, which entails obligations relating to availability, accessibility, acceptability, and quality of healthcare.33 However, the extraterritorial reach of these obligations remains contested, creating uncertainty as to whether states must actively secure health-related rights when treatment is accessed abroad.34 This uncertainty permits states to treat cross-border medical travel as a matter of private choice rather than public responsibility.
Another significant finding is the absence of enforceable patient rights in cross-border contexts. Bangladeshi patients lack clear legal entitlements concerning information disclosure, quality standards, continuity of care, or remedies for malpractice abroad. Comparative experience illustrates that patient mobility can be legally structured through supranational instruments recognizing cross-border patient rights and regulatory harmonization.35 The absence of any comparable regional framework in South Asia leaves patients dependent on the regulatory regime of destination states alone.
The study also finds that ethical vulnerability in cross-border medical tourism has legal consequences. Informed consent, autonomy, and non-discrimination are recognized principles of international human rights law, yet structural power imbalances, language barriers, and informational asymmetry undermine their effective realization in transnational healthcare settings.36 Reliance on private contractual arrangements is therefore insufficient to safeguard fundamental patient interests.
Collectively, these findings indicate that cross-border medical tourism involving Bangladeshi patients operates within an under-regulated legal space. A shift toward a rights-based regulatory approach—grounded in constitutional principles, international human rights law, and regional cooperation—is necessary to transform patient mobility from a market-driven activity into a legally protected process.
RECOMMENDATIONS
To effectively govern cross-border medical tourism, Bangladesh should establish a dedicated legal framework that clearly defines the rights, obligations, and protections of patients seeking treatment abroad. Such a framework must encompass standards for medical information, referral procedures, documentation transparency, and post-treatment follow-up, ensuring accountability and legal clarity. International human rights principles should be integrated into this framework to guarantee the availability, accessibility, acceptability, and quality of healthcare, providing a rights-based foundation for patient protection.
Bilateral and regional agreements with destination countries are essential to harmonize hospital accreditation, patient safety protocols, transparent cost structures, and dispute resolution mechanisms, thereby creating coordinated governance for cross-border care. Administrative processes, including visa approvals and procedural requirements, should be streamlined and guided by principles of procedural fairness and transparency, ensuring predictable and equitable access for all patients.
A centralized oversight body under the Ministry of Health could provide guidance to patients, maintain accredited hospital lists, and manage post-treatment follow-up and complaint resolution, reducing ethical and legal vulnerabilities. Additionally, comprehensive pre-travel counseling and awareness programs should be institutionalized to ensure patients are fully informed of treatment risks, procedures, and standards of care abroad. Ultimately, the harmonization of domestic law, bilateral agreements, and international norms will create a coherent, rights-based regulatory structure that protects patient welfare, enforces ethical standards, and ensures institutional accountability in cross-border medical tourism.
CONCLUSION
Cross-border medical tourism from Bangladesh to India and other South Asian countries reflects both structural limitations within domestic healthcare and the broader dynamics of regional health mobility. While patients seek affordable, timely, and specialized care, existing regulatory, legal, and ethical frameworks remain fragmented, creating vulnerabilities and accountability gaps. Effective governance requires a rights-based approach that harmonizes domestic law, bilateral agreements, and international human rights standards. By establishing clear legal protections, transparent administrative procedures, and centralized oversight mechanisms, Bangladesh can safeguard patient welfare, enhance equity, and ensure ethical and accountable cross-border healthcare. Such reforms are essential not only to protect individual rights but also to strengthen regional health cooperation and create a sustainable, legally coherent framework for medical tourism.
*****
Footnotes
1. David Hall, Medical Tourism: The Ethics, Regulation, and International Mobility of Patients 3–10 (2011).
2. Kelley Lee et al., Globalization, Trade and Health: Concepts and Issues 41–49 (2007)
3. Niels Boehm, Cross-Border Health Care: Policy, Law and Ethics, in Cross-Border Health Care in the European Union 9, 12–15 (2014).
4. Arjun K. Saha & Subrata Mitra, India’s Emergence as a Medical Tourism Hub, 5 Asian J. Pub. Health 21, 23–26 (2019).
5. World Bank, Bangladesh Health Sector Review: Main Report 34–38 (2022).
6. Jean V. McHale, Health Law and Policy: An Introduction 201–06 (2017).
7. Mark J. Cherry, Global Bioethics and Medical Tourism 72–78 (2014).
8. Lawrence O. Gostin & Benjamin Mason Meier, Global Health Law 289–94 (2018).
9. International Covenant on Economic, Social and Cultural Rights art. 12, Dec. 16, 1966, 993 U.N.T.S. 3.
10. Comm. on Econ., Soc. & Cultural Rts., General Comment No. 14: The Right to the Highest Attainable Standard of Health, 30–33, U.N. Doc. E/C.12/2000/4 (2000).
11. Ruth Macklin, Ethical Challenges in Medical Tourism, 31 Am. J. Bioethics 1, 3–6 (2013).
12. Kamran Abbasi, Is Medical Tourism a Problem for Public Health?, 365 BMJ 9, 10–11 (2019).
13. OECD, Health Tourism and Patient Mobility 55–60 (2011).
14. Kelley Lee & Richard Smith, Global Health Governance: Concepts, Issues and Actors, 15 Dev. Pol’y Rev. 35, 39–42 (2015).
15. Sara F. Bennett & Lucy Gilson, Health Policy Analysis: A Reader 91–95 (2017).
16. Md. Zakaria et al., Determinants of Bangladeshi Patients’ Decision-Making in Cross-Border Healthcare, 45 J. Health Servs. Res. & Pol’y 112 (2023).
17. Id.
18. John Connell, Medical Tourism, 41 Annals Tourism Res. 1 (2013).
19. Zakaria et al., supra note 1.
20. Connell, supra note 3.
21. Zakaria et al., supra note 1.
22. Iftikhar et al., Regulatory Barriers to Cross-Border Healthcare in South Asia, 19 Glob. Health Pol’y & Governance 67 (2025).
23. Id.
24. David Bookman & Karla Bookman, Medical Tourism in Developing Countries (2007).
25. Frederick Ssengooba, Institutional Constraints and Healthcare Access in Border Regions, 14 Health Pol’y Plan. 201 (2022).
26. Id.
27. Martin Rechel et al., Cross-Border Health Care in the European Union, 31 Eur. J. Pub. Health 45 (2013).
28. Pamela Andanda, Human Rights and Cross-Border Healthcare, 18 Med. L. Rev. 233 (2024).
29. Id.
30. Jiyoung Xu et al., Medical Tourism and Health Equity in South Korea, 26 Glob. Pub. Health 381 (2021).
31. Connell, supra note 3.
32. Bangladesh Const. art. 32.
33. International Covenant on Economic, Social and Cultural Rights art. 12, Dec. 16, 1966, 993 U.N.T.S. 3.
34. Comm. on Econ., Soc. & Cultural Rights, General Comment No. 14: The Right to the Highest Attainable Standard of Health, 12, U.N. Doc. E/C.12/2000/4 (2000).
35. Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the Application of Patients’ Rights in Cross-Border Healthcare, 2011 O.J. (L 88) 45.
36. Universal Declaration of Human Rights arts. 3, 25, G.A. Res. 217 (III), U.N. Doc. A/810 (Dec. 10, 1948.